Effects of prostaglandin E2 on brain edema and liver histopathology in a galactosamine-induced fulminant hepatic failure rat model.
The effects of prostaglandin E2 (PGE2) on the histopathology of liver and brain edema was studied in the galactosamine-induced fulminant hepatic failure (Ga1N-FHF) rat model. The effect of PGE2 on the development of brain edema was studied in grade II coma FHF rats by electron microscopy and by measurement of brain water content and brain swelling. Electron microscopy revealed extensive pericapillary astroglial cell swelling and morphological changes of its subcellular organelles in control FHF rats. PGE2 injected FHF rats showed reduced astroglial swelling and brain edema. PGE2 administration significantly (p less than 0.02) inhibited the progression of both brain edema and brain tissue swelling when compared with saline injected control FHF animals. However, the liver damage shown in EM assessment appeared to progress after PGE2 injection. This would appear that PGE2 is acting directly on the Blood Bain Barrier (BBB) to preserve it despite progressive hepatic failure.
D000818:Animals; D001812:Blood-Brain Barrier / Q000187:drug effects; D001929:Brain Edema / Q000188:drug therapy*; D015232:Dinoprostone; D005688:Galactosamine; D006501:Hepatic Encephalopathy / Q000139:chemically induced / Q000188:drug therapy*; D008099:Liver / Q000473:pathology*; D008297:Male; D008854:Microscopy, Electron; D011458:Prostaglandins E / Q000627:therapeutic use*; D051381:Rats; D011919:Rats, Inbred Strains
D011458:Prostaglandins E; D005688:Galactosamine; D015232:Dinoprostone